| India | Thailand | Turkey | |
| Сervix Conization | from AUD $1,233 | from AUD $3,191 | from AUD $1,741 |
| Uterine Trachelectomy | from AUD $6,528 | from AUD $13,056 | from AUD $7,978 |
| Trachelectomy (cervicectomy) | from AUD $6,528 | from AUD $10,880 | from AUD $3,627 |
| Tomotherapy | from AUD $7,543 | from AUD $43,518 | from AUD $17,407 |
| The Wertheim-Meigs operation | from AUD $6,528 | from AUD $17,407 | from AUD $18,133 |
No hidden fees – just official clinic prices. Pay at the clinic for Cervical cancer treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Cervical cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Cervical cancer treatment journey.
Professor Sridhar P.S. is a leading specialist at HCG Manavata Cancer Centre. He focuses on radiotherapy and hyperthermia for managing complex cancers.
Dr Chaitainya Borde leads the nuclear medicine department at HCG Manavata Cancer Centre. He focuses on precise diagnostic imaging and targeted therapies for complex oncological cases.
Sarat Chandra P is a dedicated medical oncologist at Manipal Hospitals, where he focuses on delivering targeted cancer therapies.
Dr Rama Joshi leads the Gynaecologic Oncology department at Fortis Memorial Research Institute, specialising in surgical management of female reproductive cancers.
Major Indian oncology centres report success rates between 85% and 95% for early-stage cervical cancer. While the national 5-year survival average is near 50%, top-tier hospitals achieve high outcomes. Facilities in Delhi and Bengaluru match global standards through multidisciplinary care and radiotherapy.
Bookimed Expert Insight: India's highest success rates are found in JCI and NABH accredited 'mega-networks'. For instance, Apollo and Manipal handle over 1,000,000 patients annually each. This high volume allows specialists to refine techniques like robotic-assisted hysterectomy. These methods often lead to better recovery than at lower-volume regional clinics.
Patient Consensus: Patients say that getting a precise stage diagnosis quickly is the most vital step. Experience in India shows that outcomes improve with coordinated care inside one hospital team.
Indian oncology centres provide cervical cancer technologies including robotic surgery, precision radiation, and molecular therapies. Hospitals such as Apollo Hospital Indraprastha use JCI-accredited infrastructure for image-guided brachytherapy and DaVinci robotic systems. These technologies aim to preserve healthy tissue and improve survival outcomes.
Bookimed Expert Insight: Technical depth in India often relies on high surgeon volume. Professor Raj Nagarkar at HCG Manavata has performed over 50,000 cancer surgeries. This high volume helps specialists successfully manage complex cases needing robotic intervention and radiotherapy.
Patient Consensus: Patients in India suggest choosing tertiary centres in major cities. This provides access to robotic units and multidisciplinary tumour boards. They note these setups lead to shorter recoveries and more accurate staging.
Younger patients can undergo fertility-sparing treatment in India for early-stage cervical cancer. Procedures like radical trachelectomy and cervical conisation allow surgeons to remove cancerous tissue while preserving the uterus. Eligibility generally requires tumours under 2 cm and no lymph node involvement.
Bookimed Expert Insight: Indian oncology centres often provide integrated services. They combine surgical oncology with nuclear medicine. For example, HCG Manavata Cancer Centre has managed over 30,000 PET scans. This high diagnostic volume helps specialists confirm if cancer is localised enough for surgery.
Patient Consensus: Patients note that eligibility depends on tumour type and size rather than age alone. Many emphasise having early discussions about pregnancy safety. They also suggest confirming that Indian specialists regularly perform these specific procedures.
Indian oncology centres report survival rates between 85% and 92% for early-stage cervical cancer. These results stem from high-volume clinical expertise and technology like CyberKnife and robotic DaVinci systems. Specialists manage thousands of cases. This helps them refine precise fertility-sparing and surgical techniques.
Bookimed Expert Insight: India's high success rates are driven by an incredible concentration of clinical experience. For example, HCG Manavata Cancer Centre has handled over 30,000 PET-CT scans for precise staging. This volume allows Indian oncologists to master complex techniques quickly.
Patient Consensus: Patients often highlight the seamless coordination between large networks like Apollo and Manipal. They find immediate access to diagnostics like PET-CT and robotic surgery helps them start treatment quickly.
Australian patients usually stay in India for 3 to 9 weeks for cervical cancer care. Early-stage surgery requires a 3 to 4 week stay. Locally advanced cases needing chemoradiation typically require 6 to 9 weeks in the country. This allows time to complete all daily treatments and recover before flying.
Bookimed Expert Insight: India ranks 6th globally for oncology requests. Major networks like Manipal and Apollo serve over 1,000,000 patients annually. While some patients consider returning home between chemotherapy cycles, those undergoing intensive chemoradiation benefit from staying in India. Clinical hubs in Delhi and Gurgaon provide integrated care where CyberKnife and robotic systems are on-site. These facilities avoid travel delays between different hospital wings during daily radiation.